I'd take a stab that it was Paul's 20m shares.
Which also explains why there wasn't a similar large jump for his ESS allocation, or for the non-Exec director remuneration.
But, all the motions not directly related to Paul had the 20m+ increase in the approve tally.
- Forums
- ASX - By Stock
- PAR
- Ann: Results of Meeting
Ann: Results of Meeting, page-4
Featured News
Add PAR (ASX) to my watchlist
(20min delay)
|
|||||
Last
22.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $78.73M |
Open | High | Low | Value | Volume |
23.0¢ | 23.0¢ | 21.5¢ | $78.13K | 350.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 64880 | 22.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
22.5¢ | 43479 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 64880 | 0.220 |
12 | 212910 | 0.215 |
14 | 245866 | 0.210 |
8 | 182478 | 0.205 |
30 | 784855 | 0.200 |
Price($) | Vol. | No. |
---|---|---|
0.225 | 43479 | 1 |
0.230 | 84999 | 2 |
0.235 | 26540 | 1 |
0.240 | 103500 | 4 |
0.250 | 109857 | 5 |
Last trade - 16.10pm 11/11/2024 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, MD & CEO
Charles Armstrong
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online